作为抑郁症患者的辅助疗法的S-Adenosylmethionine (SAMe):一个更新的系统性审查和元分析
Tzu-Rong Peng1, Han-Yu Cheng1, Ta-Wei Wu1
1Department of Pharmacy, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
General hospital psychiatry
|January 10, 2024
概括
与安慰剂或主要抑郁障碍 (MDD) 的活性抗抑郁药物相比,S-adenosyl-L-methionine (SAMe) 没有显著差异. 需要更多的研究来证实SAME.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
背景情况:
- 重度抑郁症 (MDD) 是一种需要持续治疗的持续性疾病.
- S-adenosyl-L-methionine (SAMe) 是一种天然存在的化合物,具有潜在的抗抑郁药物特性,尽管其疗效尚未完全确立.
- 这项研究系统地审查了SAME作为独立治疗或与其他抗抑郁药一起用于MDD的有效性的证据.
结论:
- 目前的证据表明,SAME在治疗严重抑郁症时可能不会比安慰剂或已确定的抗抑郁药具有显著的优势.
- 由于研究的局限性,尽管观察到的效应可能与伊米普拉或埃斯基塔洛普拉相似,但应谨慎观察.
- 建议患者咨询医疗保健专业人员,讨论MDD的所有可用的治疗方案,然后再考虑SAME.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
237
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
237
Depression: Overview
247
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
247


